Human Immunodeficiency Virus type 1 replication, immune activation, and circulating cytotoxic T cells against uninfected CD4+ T cells

Journal of Clinical Immunology

Volumn 20, Issue 3, 2000, Pages 175-186

  Kottilil, Shyamasundaran ^a   Gamberg, Jane ^a   Bowmer, Ian ^a   Trahey, Julia ^b   Howley, Constance ^b   Gallant, Maureen ^a   Grant, Michael ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b Health Care Corporation of St John's   (Canada)

Author keywords

CD4, CD8, CD28 T cells; Cytotoxic T lymphocytes; HIV; Immune activation

Indexed keywords

ARTICLE; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS REPLICATION;

ANTIGENS, CD28; BETA 2-MICROGLOBULIN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; RNA, VIRAL; T-LYMPHOCYTES, CYTOTOXIC; VIRUS REPLICATION;

EID: 0033915702     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006633429087     Document Type: Article

References (36)

1. Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure
2. T-cell-mediated immunopathology versus direct cytolysis by virus; implications for HIV and AIDS
3. - populations suggest regulatory responses linked to loss of CD4 lymphocytes
4. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes
5. + T cells
6. Auto-reactive cytotoxicity in HIV-infected individuals
7. Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection
8. Lysis of CD4+ lymphocytes by non-HLA-restricted cytotoxic T lymphocytes from HIV-infected individuals
9. + lymphocytes during HIV-1 infection
10. - cell population in the blood and lung of HIV-positive patients
11. Similar abnormalities of idiotype and immunoglobulin light chain expression and of cell-mediated cytotoxicity in HIV-infected humans and simian immunodeficiency virus (SIV)-infected macaques
12. + lymphocyte depletion in HIV-1 infection
13. + cytotoxic T lymphocyte activity in controlling HIV infection
14. Monoclonal antibody to a human histo-compatibility alloantigen. HLA-A2
15. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men
16. Seropositivity for HIV and the development of AIDS or AIDS-related conditions: Three year follow up of the San Francisco General Hospital Cohort
17. Prognosis in HIV-I infection predicted by the quantity of virus in the plasma
18. + lymphocyte homeostasis during the natural course of HIV-I infection
19. CD8 naive T cell counts decrease progressively in HIV-infected adults
20. Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells
21. + T cells in centenarians and in long-term T cell cultures: A possible cause for both in vivo and in vitro immunosenescence
22. - cells
23. - T cells in vertically HIV-infected children
24. + human T cells
25. Oligoclonal expansion and CD1 recognition by human intestinal intraepithelial lymphocytes
26. Intraepithelial lymphocytes and their recognition of non-classical MHC molecules
27. + lymphocytosis during primary simian immuno-deficiency virus infections
28. Spontaneous cytotoxicity of human intraepithelial lymphocytes against epithelial cell tumors
29. Oligoclonality of human intestinal intraepithelial T cells
30. Oligoclonality and skewed T cell receptor Vμ gene segment expression in in vivo activated human intestinal intraepithelial T lymphocytes
31. Direct ex vivo simian immunodeficlency virus specific cytotoxic activity detected from small intestinal intraepithelial lymphocytes of SIV-infected macaques at an advanced stage of infection
32. - T cell subsets in HIV type 1-infected individuals
33. + T cell responses associated with control of viremia
34. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus
35. Outpatient continuous intravenous interleukin-2 or subcutaneous polyethylene glycol-modified interleukin-2 in human immunodeficiency virus-infected patients: A randomized, controlled multicenter study